BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC. Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol 2014; 20(24): 7718-7729 [PMID: 24976709 DOI: 10.3748/wjg.v20.i24.7718]
URL: https://www.wjgnet.com/1948-5182/full/v20/i24/7718.htm
Number Citing Articles
1
KhalidA Alsuhaibani, FarisS Althunayyan, AliM Alsudays, AhmadA Alharbi, BadrM Aljarallah. Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single centerJournal of Family Medicine and Primary Care 2021; 10(9): 3381 doi: 10.4103/jfmpc.jfmpc_185_21
2
Hyunsoo Chung, Young Eun Chon, Seung Up Kim, Sang Kil Lee, Kyu Sik Jung, Kwang-Hyub Han, Chae Yoon Chon. Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation ModelDigestive Diseases and Sciences 2016; 61(2): 507 doi: 10.1007/s10620-015-3902-7
3
Josep Marí-Alexandre, Moises Barceló-Molina, Jorge Sanz-Sánchez, Pilar Molina, Jennifer Sancho, Yolanda Abellán, María Luisa Santaolaria-Ayora, Juan Giner, Luis Martínez-Dolz, Amparo Estelles, Aitana Braza-Boïls, Esther Zorio. El grosor y una expresión de miARN alterada en la grasa epicárdica se asocian con enfermedad coronaria en víctimas de muerte súbitaRevista Española de Cardiología 2019; 72(1): 30 doi: 10.1016/j.recesp.2017.12.003
4
ZHOU ZHOU, YING-CHAO LIU, XIAO-MEI CHEN, FU-QIANG LI, XIAO-JUAN TONG, YUE-PING DING, CUI-LAN TANG. Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in miceMolecular Medicine Reports 2015; 12(5): 6925 doi: 10.3892/mmr.2015.4318
5
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-based novel biomarkers for nonalcoholic steatohepatitisBiomarkers in Medicine 2018; 12(5): 501 doi: 10.2217/bmm-2017-0361
6
Huanqiu Wang, Ruyu Sun, Sisi Yang, Xueqing Ma, Chengbo Yu. Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic reviewFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.934989
7
A. Mojtahed, C. J. Kelly, A. H. Herlihy, S. Kin, H. R. Wilman, A. McKay, M. Kelly, M. Milanesi, S. Neubauer, E. L. Thomas, J. D. Bell, R. Banerjee, M. Harisinghani. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting casesAbdominal Radiology 2019; 44(1): 72 doi: 10.1007/s00261-018-1701-2
8
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
9
Yong Jiang, Tao Han, Zhi-Guang Zhang, Ying Zhang, Feng-Xiang Qi. Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitisRevista Española de Enfermedades Digestivas 2017; 110 doi: 10.17235/reed.2017.4690/2016
10
Pengzi Zhang, Wenhuan Feng, Xuehui Chu, Xitai Sun, Dalong Zhu, Yan Bi. A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levelsBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1120-z
11
Ying-Chun Lin, Horng-Yuan Wang, Yang-Che Kuo, Ming-Jen Chen, Ming-Shiang Wu, Chun-Jen Liu, Horng Woei Yang, Shou-Chuan Shih, Lo-Yip Yu, Hung-Ju Ko, Hung-I Yeh, Kuang-Chun Hu. Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adultsMedicine 2021; 100(34): e27048 doi: 10.1097/MD.0000000000027048
12
Chia-Chu Chang, Chia-Lin Wu, Wei-Wen Su, Kai-Lun Shih, Der-Cherng Tarng, Chen-Te Chou, Ting-Yu Chen, Chew-Teng Kor, Hung-Ming Wu. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver diseaseScientific Reports 2015; 5(1) doi: 10.1038/srep10096
13
Benjamin Renelus, Temitope Foster. Noninvasive evaluation of nonalcoholic fatty liver diseaseClinical Liver Disease 2016; 7(3): 45 doi: 10.1002/cld.538
14
Hedayat Allah Shahmohammadi, Seyed Ahmad Hosseini, Eskandar Hajiani, Amal Saki Malehi, Meysam Alipour. Effects of Green Coffee Bean Extract Supplementation on Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical TrialHepatitis Monthly 2017; 17(4) doi: 10.5812/hepatmon.45609
15
Zohreh Sadat Sangsefidi, Mahdieh Hosseinzadeh, Ali Mohammad Ranjbar, Mohsen Akhondi-Meybodi, Hossein Fallahzadeh, Hassan Mozaffari-Khosravi. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trialNutrition Journal 2019; 18(1) doi: 10.1186/s12937-019-0465-z
16
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosisWorld Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
17
Josep Marí-Alexandre, Moises Barceló-Molina, Jorge Sanz-Sánchez, Pilar Molina, Jennifer Sancho, Yolanda Abellán, María Luisa Santaolaria-Ayora, Juan Giner, Luis Martínez-Dolz, Amparo Estelles, Aitana Braza-Boïls, Esther Zorio. Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death VictimsRevista Española de Cardiología (English Edition) 2019; 72(1): 30 doi: 10.1016/j.rec.2017.12.007
18
Venkatanarayana Gangarapu, Ali Tüzün Ince, Birol Baysal, Yusuf Kayar, Ulkan Klç, Özlem Gök, Ömer Uysal, Hakan Şenturk. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(7): 840 doi: 10.1097/MEG.0000000000000348
19
S. V. Okovity, K. L. Raikhelson, A. V. Volnukhin, D. A. Kudlai. Hepatoprotective properties of glycyrrhizic acidExperimental and Clinical Gastroenterology 2020; (12): 96 doi: 10.31146/1682-8658-ecg-184-12-96-108
20
Kamal K. Mahawar, Chetan Parmar, Yitka Graham, Ayman Abouleid, William R. J. Carr, Neil Jennings, Norbert Schroeder, Peter K. Small. Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence BaseObesity Surgery 2016; 26(1): 177 doi: 10.1007/s11695-015-1916-z
21
Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosisExpert Review of Gastroenterology & Hepatology 2016; 10(1): 63 doi: 10.1586/17474124.2016.1099433
22
Lennard Wolff, Daniel Bos, Sarwa Darwish Murad, Oscar H. Franco, Gabriel P. Krestin, Albert Hofman, Meike W. Vernooij, Aad van der Lugt. Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam StudyEuropean Heart Journal – Cardiovascular Imaging 2016; 17(12): 1361 doi: 10.1093/ehjci/jew174
23
Oya Balcı Sezer, Derya Buluş, Şamil Hızlı, Nesibe Andıran, Deniz Yılmaz, Selma Uysal Ramadan. Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese childrenJournal of Pediatric Endocrinology and Metabolism 2016; 29(7) doi: 10.1515/jpem-2015-0426